Tag: Vaccination

GSK comes close to creating a hard-to-reach RSV vaccine

GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim...

Bavarian Nordic expects new orders for monkeypox vaccine due to strong interest

Biotechnology company Bavarian Nordic (BAVA.CO) expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from...

Bavarian Nordic signs contract to supply smallpox vaccine due to an increase in cases of monkeypox

Bavarian Nordic A/S announced today the signing of a supply contract with an undisclosed country for the Company’s smallpox...

Aspen COVID-19 vaccine plant in South Africa risks closure because of lack of orders

Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western...

WHO: Congo begins Ebola vaccination to stop outbreak in northwest of country

The Democratic Republic of Congo has kicked off Ebola vaccinations to stem an outbreak in the northwest city of...

Sputnik V demonstrates 94.8% efficacy against COVID during the vaccination in San Marino

The Russian Direct Investment Fund (RDIF) announces the real world data of the Ministry of Health of San Marino...

Moderna vaccine production continues in EU amid contamination probe

Production of Moderna COVID-19 vaccines at a plant in Spain can continue, the European Union drugs regulator said on Friday, while it carries out its investigation of a suspected metallic contamination incident.

Do I still need the vaccine if I have COVID-19?

Even if you've had COVID infection, that you should go ahead and take the vaccination when it's available to you.

One shot Sputnik Light has high safety and 93.5% efficacy against COVID

The heterogeneous boosting approach was at the core of Sputnik V, the world’s first registered vaccine against coronavirus.

FDA Authorizes Additional COVID-19 Vaccine Dose for Certain Immunocompromised Individuals

The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna Vaccines and determined that the administration of third vaccine doses may increase protection in this population.

EMA: vaccine Moderna approved for children aged 12 to 17 in EU

The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above.

Sputnik V demonstrates strong safety profile during vaccination campaign in San Marino

San Marino was the first country in Europe to defeat COVID and lift restrictions thanks to inclusion of Sputnik V vaccine in the national portfolio.